Literature DB >> 30411627

How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov.

Todd A Durham1.   

Abstract

A paper by Drs Okada and Sengoku that appears in this issue of TIRS shows how data from Clinicaltrials.gov can be used for research on the pharmaceutical industry. This commentary identifies several challenges associated with using these data for research and concludes with 3 recommendations from a statistical perspective.

Keywords:  Clinicaltrials.gov; observational research

Year:  2018        PMID： 30411627     DOI： 10.1177/2168479018811825

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN： 2168-4790            Impact factor:   1.778


  3 in total

1.  Sharing of Individual Participant Data from Clinical Trials: General Comparison and HIV Use Case.

Authors:  Craig S Mayer; Nick Williams; Sigfried Gold; Kin Wah Fung; Vojtech Huser
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

2.  Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATE.

Authors:  Teresa de Rojas; Andrew J Pearson; Nicole Scobie; Leona Knox; Darshan Wariabharaj; Pamela Kearns; Gilles Vassal; Gregory Reaman
Journal:  Cancer Med       Date:  2021-10-23       Impact factor: 4.452

3.  Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis.

Authors:  Teresa de Rojas; Anouk Neven; Mitsumi Terada; Miriam García-Abós; Lucas Moreno; Nathalie Gaspar; Julien Péron
Journal:  JNCI Cancer Spectr       Date:  2019-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.